The catalyst for research and innovation at @AkronChildrens. Focused on developing new medicines, therapies, devices & procedures to improve the health of kids.
A few of the study team for the Dupixent (dupilumab) study at Akron Children’s Hospital got together to celebrate enrolling the first patient. This study is the first for testing Dupixent for use to relieve itching in burn patients that have received skin grafts for their burns.
A sincere THANK YOU to the Hower Family and this latest gift from Mr. James H Hower! Your transformational gift enables us to live out our mission of elevating child health through discovery and innovation. Thank you for choosing to invest in pediatric research & innovation!
A gift of $6.6 million from James H. Hower will advance pediatric health care at Akron Children’s. This is the second largest individual donation in the history of the Akron Children’s Foundation
Visit our newsroom for more on the transformational gift.
https://t.co/mUslbpMbzM
The World Cardioneuroablation Congress featuring Akron Children's Dr. John Clark, director of the pediatric arrhythmia center, is taking place Oct. 21. Join us for this virtual conference and learn more about advancements in cardioneuroablation. Register: https://t.co/Q4rdKIRLWx
Team from ACH present on “Integrating Narrative Medicine in a Pediatric Clinical Setting: Understanding the Illness Experience of Children While Improving Health Outcomes" at the Communication, Medicine, and Ethics (COMET) Conference at the University of Cork, in Cork, Ireland.
Congratulations to Daniel Grossoehme for winning Best in Category for his poster, “Integrating Palliative Care into Burn Care: A Retrospective Application of Criteria for Appropriate Referral”!